Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125240671 | 12524067 | 1 | I | 20160621 | 20160704 | 20160704 | EXP | DE-CIPLA LTD.-2016DE08325 | CIPLA | KUHLMANN JB, EURINGER W, SPANGENBERG HC, BREIDERT M, BLUM HE, HARDER J ET AL.,. TREATMENT OF UNRESECTABLE CHOLANGIOCARCINOMA: CONVENTIONAL TRANSARTERIAL CHEMOEMBOLIZATION COMPARED WITH DRUG ELUTING BEAD-TRANSARTERIAL CHEMOEMBOLIZATION AND SYSTEMIC CHEMOTHERAPY. EUROPEAN JOURNAL OF GASTROENTEROLOGY + HEPATOLOGY. 2012;24 (4):437 TO 443 | 0.00 | Y | 0.00000 | 20160704 | OT | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125240671 | 12524067 | 1 | PS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | UNK | U | U | 0 | |||||||||
| 125240671 | 12524067 | 2 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | UNK | U | U | 0 | |||||||||
| 125240671 | 12524067 | 3 | SS | MITOMYCIN C | MITOMYCIN | 1 | Intra-arterial | 15 MG, UNK | U | U | 0 | 15 | MG | ||||||
| 125240671 | 12524067 | 4 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 125240671 | 12524067 | 5 | C | LIDOCAINE. | LIDOCAINE | 1 | Unknown | UNK | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125240671 | 12524067 | 1 | Cholangiocarcinoma |
| 125240671 | 12524067 | 2 | Cholangiocarcinoma |
| 125240671 | 12524067 | 5 | Local anaesthesia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125240671 | 12524067 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125240671 | 12524067 | Disease progression |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |